<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.business-standard.com/article/pti-stories/unichem-labs-gets-usfda-nod-to-market-anxiety-disorder-tablets-119111501383_1.html"/>
    <meta property="og:site_name" content="Business-Standard"/>
    <meta property="article:published_time" content="2019-11-15T13:00:00+00:00"/>
    <meta property="og:title" content="Unichem Labs gets US FDA approval to market anxiety-disorder tablets"/>
    <meta property="og:description" content="The company's tablets are a generic version of Bristol-Myers Squibb Company's Buspar tablets in the same strengths"/>
  </head>
  <body>
    <article>
      <h1>Unichem Labs gets US FDA approval to market anxiety-disorder tablets</h1>
      <h2>The company's tablets are a generic version of Bristol-Myers Squibb Company's Buspar tablets in the same strengths</h2>
      <address><time datetime="2019-11-15T13:00:00+00:00">15 Nov 2019, 13:00</time> by <a rel="author">Press Trust of India</a></address>
      <p>Drug firm <a href="https://www.business-standard.com/topic/unichem">Unichem </a>Laboratories on Friday said it has received approval from the US health regulator to market its generic Buspirone Hydrochloride tablets used for management of anxiety disorders.</p>
      <p>The company has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) to market its Buspirone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 15 mg, and 30 mg, <a href="https://www.business-standard.com/topic/unichem">Unichem </a>Laboratories said in a BSE filing.</p>
      <p>The company's tablets are a generic version of Bristol-Myers Squibb Company's Buspar tablets in the same strengths, it added.</p>
      <p>The product will be commercialised from the company's Ghaziabad plant, <a href="https://www.business-standard.com/topic/unichem">Unichem </a>said.</p>
      <p>Buspirone Hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety, it added.</p>
      <p>Shares of <a href="https://www.business-standard.com/topic/unichem-laboratories">Unichem Laboratories </a>closed at Rs 149.85 per scrip on BSE, up 5.16 per cent from its previous close.</p>
    </article>
  </body>
</html>